Researchers continue to investigate ACE inhibitor use in treating liver disease, uterine fibroids, and more. With diabetes, ACE inhibitors don’t directly lower blood sugar, but they can contribute to ...

"This is the first of seven studies that we're doing to study this medicine," he expanded, "the oral GLP-1 inhibitor that we've been developing for more than eight years. And the results are ...

Novartis has terminated a phase 2 trial evaluating an investigational ADAMTS-5 inhibitor for patients with osteoarthritis knee pain. The Big Pharma company discontinued the study testing intra ...

Here, we describe a “beads-on-a-string” (BOAS) immunogen, that tandemly links up to eight distinct hemagglutinin (HA) head domains from circulating and non-circulating influenzas. These BOAS are ...

You take an alpha-glucosidase inhibitor with the first bite of each meal. Most people take a pill three times a day. An alpha-glucosidase inhibitor will usually lower your A1c (the "average" of ...

Treatment with delgocitinib cream, a topical pan-Janus kinase inhibitor, resulted in a significant improvement in health-related quality of life in patients with moderate to severe chronic hand ...

Two proteins, the "H" and the "N" ones, stud the virus's exterior. H stands for hemagglutinin: It sticks to a cell's sugars so the virus can gain entry. N is for neuraminidase: It allows newborn ...

The presentation highlighted tolebrutinib’s potential as the first Bruton’s tyrosine kinase (BTK) inhibitor to receive regulatory approval for the treatment of progressive MS. During the Clinical ...